Advestra acted as Swiss legal counsel to Novartis, which successfully placed notes in the aggregate principal amount of USD 3.7 billion in four tranches of USD 1 billion 3.800%
Tags :Advestra
Advestra advised eMolecules and Avista Healthcare Partners (of which eMolecules is a porfolio company), on the acquisition of all shares in Synple Chem. The acquisition strategically expands eMolecules’ product and service portfolio to
A group of investors led by Verium, a multi-family office advised by Advestra, has acquired a significant minority stake in Lynus through a capital increase. Lynus is
Advestra advised UBS Switzerland as mandated lead arranger, coordinator, agent, security agent and lender together with the other syndicate banks as lenders on the EUR 200 mil
Advestra advised Liberta Partners on the acquisition of the Swiss e‑commerce company DeinDeal from Ringier, which held a majority stake in DeinDeal since 2015. Advestra’s
Advestra acted as legal counsel to Sequotech on its partnership with EVOK, an IT services provider based in Fribourg. Nexus Attorneys advised the shareholders of ALTERN8 – EVOK on the transaction.
Advestra advised Novartis on the issuance of CHF 2.2 billion bonds, placed in five tranches as follows: UBS, BNP Paribas (Suisse) and Deutsche Bank Aktiengesellschaft acted as joint lead managers
Advestra advised Barry Callebaut on the placement of CHF 730 million bonds in the Swiss market on 17 May 2024. In addition, Barry Callebaut issued Eurobonds in the amount of EUR 700 mil
Advestra advised Viseca on the placement of CHF 165 million 1.65% senior bonds due 2028, which were issued by Viseca Payment Services. Zürcher Kantonalbank, Raiffeisen Schweiz
Advestra advised Wille Finance, an international Swiss-based family office focusing on private equity / venture capital, real estate and listed assets, on its anchor investment in SwissComply, a provider of outsourcing solutions for
